Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.
about
Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic optionsInhibition of influenza virus replication by targeting broad host cell pathwaysProteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2.Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: Lessons from the 2009 pandemic.Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses.Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion.Distinct gene loci control the host response to influenza H1N1 virus infection in a time-dependent manner.A computational method for predicting regulation of human microRNAs on the influenza virus genome.Establishment of MDCK Stable Cell Lines Expressing TMPRSS2 and MSPL and Their Applications in Propagating Influenza Vaccine Viruses in Absence of Exogenous Trypsin.A mutant H3N2 influenza virus uses an alternative activation mechanism in TMPRSS2 knockout mice by loss of an oligosaccharide in the hemagglutinin stalk region.Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competenceThe Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells.Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry.Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemiaInfluenza A virus entry inhibitors targeting the hemagglutinin.Membrane-anchored serine proteases in health and disease.Novel hemagglutinin-based influenza virus inhibitors.IL-1β is a key cytokine that induces trypsin upregulation in the influenza virus-cytokine-trypsin cycleRoles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium.Antiviral strategies against influenza virus: towards new therapeutic approaches.TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.Phosphorylation of the type II transmembrane serine protease, TMPRSS13 in Hepatocyte Growth Factor Activator Inhibitor-1 and 2-mediated cell surface localization.Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses.Impact of chicken-origin cells on adaptation of a low pathogenic influenza virus.Airway protease/antiprotease imbalance in atopic asthmatics contributes to increased influenza A virus cleavage and replication.H5N1 influenza virus-like particles produced by transient expression in mammalian cells induce humoral and cellular immune responses in mice.Enhanced protective efficacy of H5 subtype influenza vaccine with modification of the multibasic cleavage site of hemagglutinin in retroviral pseudotypes.Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.Influenza glycoproteins: Hemagglutinin and neuraminidase
P2860
Q26783907-82714D9A-D6DC-47EB-B69B-9A1B303AC400Q28543978-3CCC0F01-8133-4E34-8814-A7C9971FCC5CQ30354466-63140539-525A-4D19-8BE2-D87FAD82367CQ30365699-CA939565-D0DE-4EB7-BBBF-D551D63B78B9Q30396910-DC1FF570-F60D-41B6-9471-B3C15CA7437BQ30399641-CA38AD44-3976-4712-BBAD-2A4D871E1037Q30424187-FF91E76B-BF02-4B6C-8E6C-1C21AB712C5BQ34360974-46CC2613-62AC-4694-A026-9B0E77A2D2ADQ34385369-DDFEAB12-3558-4512-B17D-2BE762DB91FBQ35101990-380A4554-3285-43D1-A38F-4E6A01C0BCFAQ35412451-4FBF9D51-D779-4A57-8F86-4F145B2FD325Q35489061-6D2098F5-A0D5-4F22-BDCF-B3F5529301DBQ35943657-A632679B-D1C4-4385-98DD-C2ED52DEBF2BQ35974128-3046ADA4-CDBB-44E2-B7DA-AD144E47891AQ36086649-2BE3C6AA-7A00-44C2-B7D3-7683196E64CEQ36294464-43F5CEBC-58B7-4869-AE89-C407C86F8778Q36586898-F915C0DC-210E-4C8D-815C-81029930CCEBQ36969010-C8F7A0B7-2269-4388-B5F3-CA9B907B332AQ37105496-0A69ECAC-A1E5-483A-AFAA-B00CDD76236BQ37578433-052066F9-037B-45BD-89A7-1277993752C8Q37825824-0E9E1694-3B62-4D67-AF70-505CC9EC96D7Q38118946-6130FED7-F12D-47BE-A801-A66B8989790CQ38202012-7DBF4D5C-D191-4AA0-A524-DD8100054230Q38339809-A43E5FC5-7AD8-461A-B0F9-3DBC54D8431CQ38678138-AF3228AD-F364-4566-870B-C11D2CB88704Q40058871-FA92A9C6-5741-4EBA-B5ED-DB20333CF299Q40079652-6437FE71-FFD3-4889-A42F-E32DDF678088Q41142462-502DB0C9-E117-47D6-A3E6-7DBD0717C26BQ42369411-8E49EDD0-BD68-4C9E-9E6B-8B0149EB7BE0Q45358893-AAC175F7-3EEF-46BC-8D36-A8CE56BBF7DFQ50943967-ABA2028D-4ACB-4222-B3B4-028F580D1EDDQ52720764-4BDF6634-20CF-4EB7-B861-DD553D388541Q57884070-B0A4F44B-3CEF-49FD-9CB6-8DE23C0BF49D
P2860
Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Novel type II transmembrane se ...... their multicycle replication.
@en
Novel type II transmembrane se ...... their multicycle replication.
@nl
type
label
Novel type II transmembrane se ...... their multicycle replication.
@en
Novel type II transmembrane se ...... their multicycle replication.
@nl
prefLabel
Novel type II transmembrane se ...... their multicycle replication.
@en
Novel type II transmembrane se ...... their multicycle replication.
@nl
P2093
P2860
P921
P356
P1433
P1476
Novel type II transmembrane se ...... their multicycle replication.
@en
P2093
Etsuhisa Takahashi
Eva Böttcher
Hiroshi Kido
Masanobu Ohuchi
Mihiro Yano
Takaaki Nakaya
Tomo Daidoji
Wolfgang Garten
Yuushi Okumura
P2860
P304
P356
10.1128/JVI.02605-09
P407
P577
2010-03-10T00:00:00Z